UNLABELLED: The gut microbiota is a complex component of humans that depends on diet, host genome, and lifestyle. The background: The study purpose is to find relations between nutrition, intestinal lactic acid bacteria (LAB) from various environments (human, animal intestine, and yogurt) and sulfate-reducing microbial communities in the large intestine; to compare kinetic growth parameters of LAB; and to determine their sensitivity to different concentration of hydrogen sulfide produced by intestinal sulfate-reducing bacteria. METHODS: Microbiological (isolation and identification), biochemical (electrophoresis), molecular biology methods (DNA isolation and PCR analysis), and statistical processing (average and standard error calculations) of the results were used. THE RESULTS: The toxicity of hydrogen sulfide produced by sulfate-reducing bacteria, the survival of lactic acid bacteria, and minimal inhibitory concentrations (MIC) were determined. The measured hydrogen sulfide sensitivity values were the same for L. paracasei and L. reuteri (MIC > 1.1 mM). In addition, L. plantarum and L.fermentum showed also a similar sensitivity (MIC > 0.45 mM) but significantly (p < 0.05) lower than L.reuteri and L. paracasei (1.1 > 0.45 mM). L. paracasei and L. reuteri are more sensitive to hydrogen sulfide than L. fermentum and L. plantarum. L. pentosus was sensitive to the extremely low concentration of H2S (MIC > 0.15 mM). CONCLUSIONS: The Lactobacillus species were significantly sensitive to hydrogen sulfide, which is a final metabolite of intestinal sulfate-reducing bacteria. The results are definitely helpful for a better understanding of complicated interaction among intestinal microbiota and nutrition.

Department of Experimental and Clinical Medicine University of Florence 50134 Florence Italy

Department of Experimental Biology Faculty of Science Masaryk University Kamenice 753 5 62500 Brno Czech Republic

Department of Plant Origin Foodstuffs Hygiene and Technology Faculty of Veterinary Hygiene and Ecology University of Veterinary and Pharmaceutical Sciences 61242 Brno Czech Republic

The Department of Environmental Protection Engineering Faculty of Technology Tomas Bata University in Zlín 76001 Zlín Czech Republic

Zobrazit více v PubMed

Million M., Diallo A., Raoult D. Gut microbiota and malnutrition. Microb. Pathog. 2017;106:127–138. doi: 10.1016/j.micpath.2016.02.003. PubMed DOI

Pagliai G., Russo E., Niccolai E., Dinu M., Di Pilato V., Magrini A., Marcucci R. Influence of a 3-month low-calorie Mediterranean diet compared to the vegetarian diet on human gut microbiota and SCFA: The CARDIVEG Study. Eur. J. Nutr. 2019;58:1–14. doi: 10.1007/s00394-019-02050-0. PubMed DOI

Niccolai E., Boem F., Russo E., Amedei A. The Gut–Brain Axis in the Neuropsychological Disease Model of Obesity: A Classical Movie Revised by the Emerging Director “Microbiome”. Nutrients. 2019;11:156. doi: 10.3390/nu11010156. PubMed DOI PMC

Russo E., Bacci G., Chiellini C., Fagorzi C., Niccolai E., Taddei A., Miloeva M. Preliminary comparison of oral and intestinal human microbiota in patients with colorectal cancer: A pilot study. Front. Microbiol. 2018;8:2699. doi: 10.3389/fmicb.2017.02699. PubMed DOI PMC

Fijan S. Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature. Int. J. Environ. Res. Public Health. 2014;11:4745–4767. doi: 10.3390/ijerph110504745. PubMed DOI PMC

Rayes N., Seehofer D., Neuhaus P. Prebiotics, probiotics, synbiotics in surgery - are they only trendy, truly effective or even dangerous? Langenbecks Arch. Surg. 2009;394:547–555. doi: 10.1007/s00423-008-0445-9. PubMed DOI

Stilesa M., Holzapfel W. Lactic acid bacteria of foods and their current taxonomy. Int. J. Food Microbiol. 1997;36:1–29. doi: 10.1016/S0168-1605(96)01233-0. PubMed DOI

Sheeladevi A., Ramanathan R. Lactic Acid Production Using Lactic Acid Bacteria under Optimized Conditions. Int. J. Pharm. Biol. Sci. Arch. 2011;2:1686–1691.

Zotta T., Ricciardi A., Ianniello R.G., Storti L.V., Glibota N.A., Parente E. Aerobic and respirative growth of heterofermentative lactic acidbacteria: A screening study. Food Microbiol. 2018;76:117–127. doi: 10.1016/j.fm.2018.02.017. PubMed DOI

Aguirre M., Collins M. Lactic acid bacteria and human clinical infection. J. Appl. Bacteriol. 1993;75:95–107. doi: 10.1111/j.1365-2672.1993.tb02753.x. PubMed DOI

Gibson G.R., Cummings J.H., Macfarlane G.T. Growth and activities of sulphate-reducing bacteria in gut contents of health subjects and patients with ulcerative colitis. FEMS Microbiol. Ecol. 1991;86:103–112. doi: 10.1111/j.1574-6968.1991.tb04799.x. DOI

Cummings J.H., Macfarlane G.T., Macfarlane S. Intestinal Bacteria and Ulcerative Colitis. Curr. Issues Intest. Microbiol. 2003;4:9–20. PubMed

Kováč J., Vítězová M., Kushkevych I. Metabolic activity of sulfate-reducing bacteria from rodents with colitis. Open Med. 2018;13:344–349. PubMed PMC

Kushkevych I., Vítězová M., Fedrová P., Vochyanová Z., Paráková L., Hošek J. Kinetic properties of growth of intestinal sulphate-reducing bacteria isolated from healthy mice and mice with ulcerative colitis. Acta Vet. Brno. 2017;86:405–411. doi: 10.2754/avb201786040405. DOI

Kushkevych I., Fafula R., Parak T., Bartoš M. Activity of Na+/K+-activated Mg2+-dependent ATP hydrolase in the cell-free extracts of the sulfate-reducing bacteria Desulfovibrio piger Vib-7 and Desulfomicrobium sp. Rod-9. Acta Vet. Brno. 2015;84:3–12. doi: 10.2754/avb201585010003. DOI

Kushkevych I.V. Activity and kinetic properties of phosphotransacetylase from intestinal sulfate-reducing bacteria. Acta Biochem. Pol. 2015;62:1037–1108. doi: 10.18388/abp.2014_845. PubMed DOI

Kushkevych I.V. Kinetic Properties of Pyruvate Ferredoxin Oxidoreductase of Intestinal Sulfate-Reducing Bacteria Desulfovibrio piger Vib-7 and Desulfomicrobium sp. Rod-9. Pol. J. Microbiol. 2015;64:107–114. PubMed

Kushkevych I., Dordević D., Kollar P., Vítězová M., Drago L. Hydrogen Sulfide as a Toxic Product in the Small–Large Intestine Axis and its Role in IBD Development. J. Clin. Med. 2019;8:1054. doi: 10.3390/jcm8071054. PubMed DOI PMC

Kushkevych I., Dordević D., Vítězová M. Toxicity of hydrogen sulfide toward sulfate-reducing bacteria Desulfovibrio piger Vib-7. Arch. Microbiol. 2019;201:389–397. doi: 10.1007/s00203-019-01625-z. PubMed DOI

Florin T.H., Neale G., Goretski S. Sulfate in food and beverages. J. Food Compos. Anal. 1993;6:140–151. doi: 10.1006/jfca.1993.1016. DOI

Ananthakrishnan A.N. Epidemiology and risk factors for IBD. Reviews Gastroenterology & Hepatology. Nat. Rev. Gastroenterol. Hepatol. 2015;12:205–217. PubMed

Weisburg W., Barns S., Pelletier D.L. 16S ribosomal DNA amplification for phylogenetic study. J. Bacteriol. 1991;173:697–703. doi: 10.1128/jb.173.2.697-703.1991. PubMed DOI PMC

Bailey N.T.J. Statistical Methods in Biology. Cambridge University Press; Cambridge, UK: 1995.

Ng S., Shi H., Hamidi N., Underwood F., Tang W., Benchimol E., Kaplan G. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet. 2017;390:2769–2778. doi: 10.1016/S0140-6736(17)32448-0. PubMed DOI

Ndeh D., Gilbert H. Biochemistry of complex glycan depolymerisation by the human gut microbiota. FEMS Microbiol. Rev. 2018;42:146–164. doi: 10.1093/femsre/fuy002. PubMed DOI

Heeney D., Gareau M., Marco M. Intestinal Lactobacillus in health and disease, a driver or just along for the ride? Curr. Opin. Biotechnol. 2018;49:140–147. doi: 10.1016/j.copbio.2017.08.004. PubMed DOI PMC

Cho H.Y., Yousef A.E., Sastry S.K. Growth kinetics of Lactobacillus acidophilus under ohmic heating. Biotechnol. Bioeng. 1996;49:334–340. doi: 10.1002/(SICI)1097-0290(19960205)49:3<334::AID-BIT12>3.0.CO;2-E. PubMed DOI

Brizuela M., Serrano P., Pérez Y. Studies on Probiotics Properties of Two Lactobacillus Strains. Braz. Arch. Biol. Technol. 2001;44:95–99. doi: 10.1590/S1516-89132001000100013. DOI

Gorbach S.L., Goldin B. Lactobacillus. United States Pat. 1991;32:399.

Kimura H. Production and Physiological Effects of Hydrogen Sulfide. Antioxid. Redox Signal. 2014;20:783–793. doi: 10.1089/ars.2013.5309. PubMed DOI PMC

Rowan F.E., Docherty N.G., Coffey J.C., O’Connell P.R. Sulphate-reducing bacteria and hydrogen sulphide in the aetiology of ulcerative colitis. Br. J. Surg. 2009;96:151–158. doi: 10.1002/bjs.6454. PubMed DOI

Reis M., Almeida J., Lemos P., Carrondo M. Effect of hydrogen sulfide on growth of sulfate reducing bacteria. Biotechnol. Bioeng. 1992;40:593–600. doi: 10.1002/bit.260400506. PubMed DOI

Blachier F., Beaumont B., Kim E. Cysteine-derived hydrogen sulfide and gut health: A matter of endogenous or bacterial origin. Curr. Opin. Clin. Nutr. Metab. Care. 2019;22:68–75. doi: 10.1097/MCO.0000000000000526. PubMed DOI

Kushkevych I., Dordević D., Vítězová M., Kollár P. Cross-correlation analysis of the Desulfovibrio growth parameters of intestinal species isolated from people with colitis. Biologia. 2018;73:1137–1143. doi: 10.2478/s11756-018-0118-2. DOI

Kushkevych I., Dordević D., Vítězová M. Analysis of pH dose-dependent growth of sulfate-reducing bacteria. Open Med. 2019;14:66–74. doi: 10.1515/med-2019-0010. PubMed DOI PMC

Kushkevych I., Dordević D., Kollar P. Analysis of physiological parameters of Desulfovibrio strains from individuals with colitis. Open Life Sci. 2018;13:481–488. doi: 10.1515/biol-2018-0057. PubMed DOI PMC

Kushkevych I., Vítězová M., Kos J., Kollár P., Jampilek J. Effect of selected 8-hydroxyquinoline-2-carboxanilides on viability and sulfate metabolism of Desulfovibrio piger. J. Appl. Biomed. 2018;16:241–246. doi: 10.1016/j.jab.2018.01.004. DOI

Kushkevych I., Kollar P., Suchy P., Parak T., Pauk K., Imramovsky A. Activity of selected salicylamides against intestinal sulfate-reducing bacteria. Neuroendocrinol. Lett. 2015;36:106–113. PubMed

Kushkevych I., Kollar P., Ferreira A.L., Palma D., Duarte A., Lopes M.M., Bartos M., Pauk K., Imramovsky A., Jampilek J. Antimicrobial effect of salicylamide derivatives against intestinal sulfate-reducing bacteria. J. Appl. Biomed. 2016;14:125–130. doi: 10.1016/j.jab.2016.01.005. DOI

Kushkevych I., Kos J., Kollar P., Kralova K., Jampilek J. Activity of ring-substituted 8-hydroxyquinoline- 2-carboxanilides against intestinal sulfate-reducing bacteria Desulfovibrio piger. Med. Chem. Res. 2018;27:278–284. doi: 10.1007/s00044-017-2067-7. DOI

Gibson G.R., Macfarlane S., Macfarlane G.T. Metabolic interactions involving sulphate-reducing and methanogenic bacteria in the human large intestine. FEMS Microbiol. Ecol. 1993;12:117–125. doi: 10.1111/j.1574-6941.1993.tb00023.x. DOI

Loubinoux J., Bronowicji J.P., Pereira I.A. Sulphate-reducing bacteria in human feces and their association with inflammatory diseases. FEMS Microbiol. Ecol. 2002;40:107–112. doi: 10.1111/j.1574-6941.2002.tb00942.x. PubMed DOI

Loubinoux J., Mory F., Pereira I.A., Le Faou A.E. Bacteremia caused by a strain of Desulfovibrio related to the provisionally named Desulfovibrio fairfieldensis. J. Clin. Microbiol. 2000;38:931–934. PubMed PMC

Loubinoux J., Valente F.M.A., Pereira I.A.C. Reclassification of the only species of the genus Desulfomonas, Desulfomonas pigra, as Desulfovibrio piger comb. nov. Int. J. Syst. Evol. Microbiol. 2002;52:1305–1308. PubMed

Kushkevych I., Vítězová M., Vítěz T., Bartoš M. Production of biogas: Relationship between methanogenic and sulfate-reducing microorganisms. Open Life Sci. 2017;12:82–91. doi: 10.1515/biol-2017-0009. DOI

Kushkevych I., Vítězová M., Vítěz T., Kovac J., Kaucká P., Jesionek W., Bartoš M., Barton L. A new combination of substrates: Biogas production and diversity of the methanogenic microorganisms. Open Life Sci. 2018;13:119–128. doi: 10.1515/biol-2018-0017. PubMed DOI PMC

Kushkevych I., Kováč J., Vítězová M., Vítěz T., Bartoš M. The diversity of sulfate-reducing bacteria in the seven bioreactors. Arch. Microbiol. 2018;200:945–950. doi: 10.1007/s00203-018-1510-6. PubMed DOI

Pitcher M.C., Cummings J.H. Hydrogen sulphide: A bacterial toxin in ulcerative colitis? Gut. 1996;39:1–4. doi: 10.1136/gut.39.1.1. PubMed DOI PMC

Blachier F., Davila A.M., Mimoun S. Luminal sulfide and large intestine mucosa: Friend or foe? Amino Acids. 2010;39:335–347. doi: 10.1007/s00726-009-0445-2. PubMed DOI

Beauchamp R.O., Bus J.S., Popp J.A., Boreiko C.J., Andjelkovich D.A., Leber P. A critical review of the literature on hydrogen sulfide toxicity. Crc. Crit. Rev. Toxicol. 1984;13:25–97. doi: 10.3109/10408448409029321. PubMed DOI

Grieshaber M.K., Völkel S. Animal adaptations for tolerance and exploitation of poisonous sulfide. Annu. Rev. Physiol. 1998;60:33–53. doi: 10.1146/annurev.physiol.60.1.33. PubMed DOI

Černý M., Vítězová M., Vítěz T., Bartoš M., Kushkevych I. Variation in the Distribution of Hydrogen Producers from the Clostridiales Order in Biogas Reactors Depending on Different Input Substrates. Energies. 2018;11:3270.

Kováč J., Kushkevych I. New modification of cultivation medium for isolation and growth of intestinal sulfate-reducing bacteria; Proceedings of the International PhD Students Conference MendelNet; Brno, Czech Republic. 6–7 November 2019; pp. 702–707.

Kotrsová V., Kushkevych I. Possible methods for evaluation of hydrogen sulfide toxicity against lactic acid bacteria. Biointerface Res. Appl. Chem. 2019;9:4066–4069.

Tomasova L., Konopelski P., Ufnal M. Gut bacteria and hydrogen sulfide: The new old players in circulatory system homeostasis. Molecules. 2016;21:1558. doi: 10.3390/molecules21111558. PubMed DOI PMC

Tomasova L., Dobrowolski L., Jurkowska H., Wróbel M., Huc T., Ondrias K., Ufnal M. Intracolonic hydrogen sulfide lowers blood pressure in rats. Nitric Oxide. 2016;60:50–58. doi: 10.1016/j.niox.2016.09.007. PubMed DOI

Bronowicka-Adamska P., Wróbel M., Magierowski M., Magierowska K., Kwiecień S., Brzozowski T. Hydrogen sulphide production in healthy and ulcerated gastric mucosa of rats. Molecules. 2017;22:530. doi: 10.3390/molecules22040530. PubMed DOI PMC

Comparison of microbial communities and the profile of sulfate-reducing bacteria in patients with ulcerative colitis and their association with bowel diseases: a pilot study

NADH and NADPH peroxidases as antioxidant defense mechanisms in intestinal sulfate-reducing bacteria

Sulfur content in foods and beverages and its role in human and animal metabolism: A scoping review of recent studies

Gut microbe Lactiplantibacillus plantarum undergoes different evolutionary trajectories between insects and mammals

ATPase Activity of the Subcellular Fractions of Colorectal Cancer Samples under the Action of Nicotinic Acid Adenine Dinucleotide Phosphate

Microscopic Methods for Identification of Sulfate-Reducing Bacteria from Various Habitats

Intestinal Microbiota and Perspectives of the Use of Meta-Analysis for Comparison of Ulcerative Colitis Studies

Hydrogen sulfide toxicity in the gut environment: Meta-analysis of sulfate-reducing and lactic acid bacteria in inflammatory processes

Sulfate-Reducing Bacteria of the Oral Cavity and Their Relation with Periodontitis-Recent Advances

Evaluation of Physiological Parameters of Intestinal Sulfate-Reducing Bacteria Isolated from Patients Suffering from IBD and Healthy People

Adenosine-5'-Phosphosulfate- and Sulfite Reductases Activities of Sulfate-Reducing Bacteria from Various Environments

The Characterization of Enterococcus Genus: Resistance Mechanisms and Inflammatory Bowel Disease

Recent Advances in Metabolic Pathways of Sulfate Reduction in Intestinal Bacteria